Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 16

1.

Important differences in mode of death between men and women with heart failure who would qualify for a primary prevention implantable cardioverter-defibrillator.

Rho RW, Patton KK, Poole JE, Cleland JG, Shadman R, Anand I, Maggioni AP, Carson PE, Swedberg K, Levy WC.

Circulation. 2012 Nov 13;126(20):2402-7. doi: 10.1161/CIRCULATIONAHA.111.069245. Epub 2012 Oct 16. Erratum in: Circulation. 2013 Apr 9;127(14):E541.

2.
3.

Predictors of mortality in patients with an implantable cardiac defibrillator: a systematic review and meta-analysis.

Alba AC, Braga J, Gewarges M, Walter SD, Guyatt GH, Ross HJ.

Can J Cardiol. 2013 Dec;29(12):1729-40. doi: 10.1016/j.cjca.2013.09.024. Epub 2013 Oct 1. Review.

PMID:
24267811
4.

Gender differences in clinical outcome and primary prevention defibrillator benefit in patients with severe left ventricular dysfunction: a systematic review and meta-analysis.

Santangeli P, Pelargonio G, Dello Russo A, Casella M, Bisceglia C, Bartoletti S, Santarelli P, Di Biase L, Natale A.

Heart Rhythm. 2010 Jul;7(7):876-82. doi: 10.1016/j.hrthm.2010.03.042. Epub 2010 Apr 7. Review.

PMID:
20380893
5.

[In patients with heart failure, do implantable cardioverter-defibrillators delay death or save lives?].

Berisso MZ, Delfino L, Viani S.

Ital Heart J Suppl. 2002 Jan;3(1):36-44. Review. Italian.

PMID:
11899573
6.

New primary prevention trials of sudden cardiac death in patients with left ventricular dysfunction: SCD-HEFT and MADIT-II.

Klein H, Auricchio A, Reek S, Geller C.

Am J Cardiol. 1999 Mar 11;83(5B):91D-97D. Review.

PMID:
10089848
7.

Indications for ICD and cardiac resynchronization therapy for prevention of sudden cardiac death.

Das M.

Expert Rev Cardiovasc Ther. 2009 Feb;7(2):181-95. doi: 10.1586/14779072.7.2.181. Review.

PMID:
19210214
8.

The implantable cardioverter defibrillator as a "bridge to transplant": a viable clinical strategy?

Schmidinger H.

Am J Cardiol. 1999 Mar 11;83(5B):151D-157D. Review.

PMID:
10089858
9.

Can implantable defibrillators reduce non-arrhythmic mortality?

Nisam S.

J Interv Card Electrophysiol. 1998 Dec;2(4):371-5. Review.

PMID:
10027124
10.
11.

Pacemakers and defibrillators for congestive heart failure.

Mehta D, Langan MN, Banker J.

Curr Cardiol Rep. 2001 Mar;3(2):119-23. Review.

PMID:
11177668
12.

Risk stratification for sudden death in heart failure.

Farwell D, Gollob MH.

Minerva Cardioangiol. 2007 Jun;55(3):379-84. Review.

PMID:
17534256
13.

Use of implantable cardioverter-defibrillators for primary prevention in older patients: a systematic literature review and meta-analysis.

Kong MH, Al-Khatib SM, Sanders GD, Hasselblad V, Peterson ED.

Cardiol J. 2011;18(5):503-14. Review. Erratum in: Cardiol J. 2012;19(4):442.

14.

Sex differences in ICD benefit.

Bergau L, Seegers J, Zabel M.

J Electrocardiol. 2014 Nov-Dec;47(6):869-73. doi: 10.1016/j.jelectrocard.2014.08.007. Epub 2014 Aug 12. Review.

PMID:
25240806
15.

End-of-life matters in chronic heart failure patients.

Sobanski P, Jaarsma T, Krajnik M.

Curr Opin Support Palliat Care. 2014 Dec;8(4):364-70. doi: 10.1097/SPC.0000000000000094. Review.

16.

[Sudden death in young athletes].

Makarov LM.

Kardiologiia. 2010;50(2):78-83. Review. Russian. No abstract available.

PMID:
20146684

Supplemental Content

Support Center